John W. Wilks - Concepedia

Author

John W. Wilks

W.E. Upjohn Institute for Employment Research

Also Known As

J Wilks, J. W. WILKS, J. W. Wilks, J.W. Wilks, JOHN W. WILKS, John W. Wilks

Publications

1.5K

Citations

H-Index

Concepts

All Affiliations

W.E. Upjohn Institute for Employment Research National Institutes of Health Eunice Kennedy Shriver National Institute of Child Health and Human Development West Michigan Cancer Center Cornell University

About

John W. Wilks is an author at W.E. Upjohn Institute for Employment Research specializing in medicine, endocrinology, and physiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	18	28	1.2K
2	Public Health	12	14	550
3	Biochemistry	5	5	187
4	Natural Sciences	2	2	126
5	Social Sciences	1	1	13

John W. Wilks

Publications

1.4K

Citations

H-Index

Page 1

	Year	Citations
Specific inhibition of endothelial cell proliferation by thrombospondin P. Bagavandoss, John W. Wilks Biochemical and Biophysical Research Communications ThrombopoiesisThrombosisBlood PlateletMedicineEndothelial Dysfunction	1990	167
A New Radioimmunoassay for Follicle-Stimulating Hormone in Macaques: Ovulatory Menstrual Cycles Gary D. Hodgen, John W. Wilks, Judith L. Vaitukaitis, Endocrinology Hormonal ContraceptiveFertilityReproductive HealthImmunologyGynecology	1976	146
The tetracycline analogs minocycline and doxycycline inhibit angiogenesis in vitro by a non-metalloproteinase-dependent mechanism S. Gilbertson-Beadling, Elaine A. Powers, M. Stamp-Cole, Cancer Chemotherapy and Pharmacology InflammationAngiogenesisTetracycline Analogs MinocyclineNon-metalloproteinase-dependent MechanismMedicine	1995	126
Luteal Phase Defects in the Rhesus Monkey: The Significance of Serum FSH:LH Ratios John W. Wilks, Gary D. Hodgen, Griff T. Ross The Journal of Clinical Endocrinology & Metabolism FertilitySerum FshGynecologyFemale Reproductive FunctionMenstrual Cycle	1976	113
Modulation of bovine microvascular endothelial cell proteolytic properties by inhibitors of angiogenesis Michael S. Pepper, J D Vassalli, Lelio Orci, Journal of Cellular Biochemistry	1994	85
Structural characterizations of nonpeptidic thiadiazole inhibitors of matrix metalloproteinases reveal the basis for stromelysin selectivity B.C. Finzel, Eric T. Baldwin, G. L. Bryant, Protein Science Matrix Metalloproteinase StromelysinBioorganic ChemistryStromelysin SelectivityMolecular BiologyChemical Biology	1998	69
Synthesis of a Series of Stromelysin-Selective Thiadiazole Urea Matrix Metalloproteinase Inhibitors E. Jon Jacobsen, Mark A. Mitchell, Susan K. Hendges, Journal of Medicinal Chemistry Medicinal ChemistryAmino Acid ComponentBioorganic ChemistryPharmaceutical ScienceBiochemistry	1999	57
Steroidogenic Responsiveness of the Monkey Corpus Luteum to Exogenous Chorionic Gonadotropin* John W. Wilks, Andrew S. Noble Endocrinology Hormonal ContraceptiveFertilityReproductive HealthGynecologyMenstrual Cycle	1983	57
Synthetic matrix metalloproteinase inhibitors and tissue inhibitor of metalloproteinase (TIMP)-2, but not TIMP-1, inhibit shedding of tumor necrosis factor-alpha receptors in a human colon adenocarcinoma (Colo 205) cell line. M A Lombard, T L Wallace, Marc F. Kubicek, PubMed Colo 205ImmunologyPathologyCancer BiologyTumor Biology	1998	56
Inhibition of Angiogenesis with Combination Treatments of Angiostatic Steroids and Suramin John W. Wilks, P. S. Scott, L.K. Vrba, International Journal of Radiation Biology AngiogenesisMedicineCombination TreatmentsAngiostatic SteroidsVascular Biology	1991	50

Page 1